Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-15,000
Closed -$10.8K 34
2025
Q1
$10.8K Hold
15,000
﹤0.01% 119
2024
Q4
$17.9K Hold
15,000
0.01% 121
2024
Q3
$50.4K Hold
15,000
0.02% 123
2024
Q2
$79.5K Hold
15,000
0.03% 106
2024
Q1
$79.5K Buy
+15,000
New +$85.4K 0.04% 105

Other funds holding AFMD

Clayton Financial Group's AFMD Position: Q2 2025 in Review

Clayton Financial Group sold out of Affimed (AFMD) in Q2 2025, closing a stake of 15,000 shares — an estimated $10.8K sold.

Clayton Financial Group first reported a position in AFMD in Q1 2024 and held it in 5 quarters. The position peaked at $79.5K in Q2 2024. 3 funds tracked by Wall St. Rank hold AFMD as of Q2 2025.

  • Clayton Financial Group reported no remaining Affimed position as of Q2 2025 after selling out during the quarter.
  • Clayton Financial Group sold 15,000 Affimed shares in Q2 2025, an estimated $10.8K.
  • Clayton Financial Group first reported a position in Affimed in Q1 2024 and held it in 5 quarters.
  • Clayton Financial Group's Affimed position peaked at $79.5K in Q2 2024.
  • 3 funds tracked by Wall St. Rank held Affimed as of Q2 2025.

Based on Clayton Financial Group's 13F filing for Q2 2025, filed 14 Jul 2025.